In February this year Swiss healthcare group Novartis announced its
intention to divest itself of the Health and Functional Food
(H&FF) arm of its Consumer Health sector business in order to
focus on the core pharmaceutical business....
US health science company Forbes Medi-Tech announced this week that
it has exercised its right not to buy back the licensing and
distribution rights to its cholesterol-lowering food ingredient
Reducol from Novartis Consumer Health...
Swiss pharmaceutical company Novartis, Europe's third-biggest
healthcare group, said on Thursday that net profit for 2001 had
risen by eight per cent to 7.0 billion Swiss francs (€4.7 bn) as
flagship drug sales rose 15 per cent...